T1 mapping
Biomarker2 papers
- Humans1
Latest
6Nature MedicineHuman trial
Semaglutide may protect kidneys by reducing vascular resistance
In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering…In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering coprimary imaging endpoints.
International Urology and NephrologyHumans
Obesity and reduced renal corticomedullary differentiation on T1 mapping: a population-based UK Biobank study
European Heart Journal Cardiovascular ImagingHumans
Left Ventricular Fibrosis on T1 Mapping is Associated with Increased Risk of Incident Atrial Fibrillation: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)
ADA Scientific Sessions 2026 AbstractHuman trial